RIPK1 and cancer: Because JNK is activated by cisplatin to induce apoptosis for killing cancer cells and RIP1 is involved in JNK induction by diverse stimuli [6, 8, 25-27], we examined cisplatin-induced JNK activation and found it was dramatically potentiated by RIP1 suppression (Fig. 1C, 1D).